Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
AIM ImmunoTech Inc (AIM)
NYSE MKT:AIM
AIM ImmunoTech (AIM) Stock Price & Analysis
771 Followers
AIM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.29 - $1.38
Previous Close$0.4
Volume22.04K
Average Volume (3M)254.19K
Market Cap
$19.35M
Enterprise Value$19.24M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.9
Beta0.54
Next Earnings
Mar 31, 2023EPS Estimate
-$0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding39,690,012
10 Day Avg. Volume106,791
30 Day Avg. Volume254,189
Standard Deviation0.28
R-Squared0.00190
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.51
Price to Sales (P/S)196.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue170.25
Enterprise Value/Gross Profit-26.91
Enterprise Value/Ebitda-1.35
Forecast
1Y Price Target
$3.00Price Target Upside645.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
AIM ImmunoTech News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AIM FAQ
What was AIM ImmunoTech Inc’s price range in the past 12 months?
AIM ImmunoTech Inc lowest stock price was $0.29 and its highest was $1.38 in the past 12 months.
What is AIM ImmunoTech Inc’s market cap?
Currently, no data Available
When is AIM ImmunoTech Inc’s upcoming earnings report date?
AIM ImmunoTech Inc’s upcoming earnings report date is Mar 31, 2023 which is in 2 days.
How were AIM ImmunoTech Inc’s earnings last quarter?
AIM ImmunoTech Inc released its earnings results on Nov 15, 2022. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.093 by -$0.037.
Is AIM ImmunoTech Inc overvalued?
According to Wall Street analysts AIM ImmunoTech Inc’s price is currently Undervalued.
Does AIM ImmunoTech Inc pay dividends?
AIM ImmunoTech Inc does not currently pay dividends.
What is AIM ImmunoTech Inc’s EPS estimate?
AIM ImmunoTech Inc’s EPS estimate is -$0.12.
How many shares outstanding does AIM ImmunoTech Inc have?
AIM ImmunoTech Inc has 48,082,275 shares outstanding.
What happened to AIM ImmunoTech Inc’s price movement after its last earnings report?
AIM ImmunoTech Inc reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.093. Following the earnings report the stock price went up 4.167%.
Which hedge fund is a major shareholder of AIM ImmunoTech Inc?
Currently, no hedge funds are holding shares in AIM
---
AIM ImmunoTech Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (645.53% Upside)
$3.00 (645.53% Upside)
Insider Transactions
Bought Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.96%
12-Months-Change
Fundamentals
Return on Equity
-39.91%
Trailing 12-Months
Asset Growth
-26.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AIM ImmunoTech Inc
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.
---
Top 5 ETFs holding AIM
iShares Core S&P Total U.S. Stock Market ETF
Up to five ETFs with an Outperform Smart Score that hold AIM. The ETFs are listed according to market value of AIM within the ETF
---
---